Massachusetts Life Sciences Initiative Offers Biotech Industry $250 Million in Tax Benefits

Practical U.S./Domestic Tax Strategies, October 2008

Joseph X. Donovan and Jill Tenley Oldak wrote an article entitled "Massachusetts Life Sciences Initiative Offers Biotech Industry $250 Million in Tax Benefits," which describes how one quarter of the Commonwealth’s new $1 billion life sciences initiative, signed into law by Governor Deval Patrick on June 16, 2008, has been set aside for tax incentives for life sciences companies, placing Massachusetts in the forefront among states using tax policy to attract biopharmaceutical development.